|
1.
|
Silvestri L, Sonzogni L, De Silvestri A,
et al: CYP enzyme polymorphisms and susceptibility to HCV-related
chronic liver disease and liver cancer. Int J Cancer. 104:310–317.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Kirk GD, Lesi OA, Mendy M, et al: 249(ser)
TP53 mutation in plasma DNA, hepatitis B viral infection, and risk
of hepato-cellular carcinoma. Oncogene. 24:5858–5867. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Hara A, Sakata K, Yamada Y, et al:
Suppression of β-catenin mutation by dietary exposure of auraptene,
a citrus antioxidant, in N,N-diethylnitrosamine-induced
hepatocellular carcinomas in rats. Oncol Rep. 14:345–351. 2005.
|
|
4.
|
Marrero JA, Fontana RJ, Fu S, et al:
Alcohol, tobacco and obesity are synergistic risk factors for
hepatocellular carcinoma. J Hepatol. 42:218–224. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Zhang X, Miao X, Liang G, et al:
Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and
risk of lung cancer. Cancer Res. 65:722–726. 2005.PubMed/NCBI
|
|
6.
|
Gerlitz G: HMGNs. DNA repair and cancer.
Biochim Biophys Acta. 1799:80–85. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Song DK, Xing DL, Zhang LR, et al:
Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene
polymorphisms with susceptibility and clinicopathologic
characteristics of bladder cancer in Central China. Cancer Detect
Prev. 32:416–423. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Ginsberg G, Angle K, Guyton K and Sonawane
B: Polymorphism in the DNA repair enzyme XRCC1: Utility of current
database and implications for human health risk assessment. Mutat
Res. 727:13–15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Lindahl T and Wood RD: Quality control by
DNA repair. Science. 286:1897–1905. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Shen MR, Jones LM and Mohrenweiser H:
Nonconservative amino acid substitution variants exist at
polymorphic frequency in DNA repair genes in healthy humans. Cancer
Res. 58:604–608. 1998.PubMed/NCBI
|
|
11.
|
Xing D, Qi J, Miao X, et al: Polymorphisms
of DNA repair genes XRCC1 and XPD and their associations with risk
of esophageal squamous cell carcinoma in a Chinese population. Int
J Cancer. 100:600–605. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Lee SG, Kim B, Choi J, et al: Genetic
polymorphisms of XRCC1 and risk of gastric cancer. Cancer Lett.
187:53–60. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Park JY, Lee SY, Jeon HS, et al:
Polymorphism of the DNA repair gene XRCC1 and risk of primary lung
cancer. Cancer Epidemiol Biomarkers Prev. 11:23–27. 2002.
|
|
14.
|
Kim SU, Park SK, Yoo KY, et al: XRCC1
genetic polymorphism and breast cancer risk. Pharmacogenetics.
12:335–338. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Au WW, Salama SA and Sierra-Torres CH:
Functional characterization of polymorphisms in DNA repair genes
using cytogenetic challenge assays. Environ Health Perspect.
111:1843–1850. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Liang G, Xing D, Miao XD, et al: Sequence
variations in the DNA repair gene XPD and risk of lung cancer in a
Chinese population. Int J Cancer. 105:669–673. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Abdel-Rahman SZ, Soliman AS, Bondy ML, et
al: Inheritance of the 194Trp and the 399Gln variant alleles of the
DNA repair gene XRCC1 are associated with increased risk of
early-onset colorectal carcinoma in Egypt. Cancer Lett. 159:79–86.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
David-Beabes GL and London SJ: Genetic
polymorphism of XRCC1 and lung cancer risk among African-Americans
and Caucasians. Lung Cancer. 34:333–339. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Lunn RM, Langlois RG, Hsieh LL, et al:
XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and
glycophorin A variant frequency. Cancer Res. 59:2557–2561.
1999.PubMed/NCBI
|
|
20.
|
Kiran M, Saxena R, Chawla YK, et al:
Polymorphism of DNA repair gene XRCC1 and hepatitis-related
hepatocellular carcinoma risk in Indian population. Mol Cell
Biochem. 327:7–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Cheng L, Spitz MR, Hong WK and Wei Q:
Reduced expression levels of nucleotide excision repair genes in
lung cancer. Carcinogenesis. 21:1527–1530. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Vogel U, Nexø BA, Tjønneland A, et al:
ERCC1, XPD and RAI mRNA levels in lymphocytes are not associated
with lung cancer risk in a prospective study of Danes. Mutat Res.
593:88–96. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Long XD, Ma Y, Zhou YF, et al: XPD codon
312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular
carcinoma risk. BMC Cancer. 17:4002009. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Long XD, Ma Y, Wei YP, et al: The
polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and
aflatoxin B1-related hepatocellular carcinoma in Guangxi
population, China. Hepatol Res. 36:48–55. 2006.PubMed/NCBI
|
